Psoriasis can affect other parts of the body, too, including the joints, causing the condition known as psoriatic arthritis. The amount of people with psoriasis who develop psoriatic arthritis ranges ...
When compared with other biologic therapies, patients with psoriasis receiving IL-23 inhibitors had a lower risk for inflammatory arthritis or psoriatic arthritis development.
Tumor necrosis factor inhibitor drugs industry is projected to witness a CAGR of 2.2% during the period 2024-2032. This growth can be attributed to advancements in biotechnology and drug ...